Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pablo Zuanic

Update On Cannabis M&A: Aurora, TerrAscend, SNDL, Curaleaf, And… A Costly Preferred Stock Raise?

On Thursday, analyst Pablo Zuanic from Cantor Fitzgerald offered an industry update on four recent M&A deals and Glasshouse Series B Preferred stock issuance.

Benzinga

Jushi's Earnings Power Grows But This Analyst Remains Sidelined, Here's Why

Cannabis company Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) reported a 52.4% year-over-year increase in second-quarter revenue to $72.8 million, attributing

Benzinga

Why Should Cannabis Investors Pay Attention To Germany? These Stocks Will Benefit From Imminent Legalization

With US federal legalization stalled and its near-term outcome uncertain, cannabis stocks are taking a hit. Cantor Fitzgerald's analyst Pablo Zuanic advised investors to turn their interest to Germany, or at least for now.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

'One Of Best-In-Class' Cannabis MSOs Has 'Optionality' When States Go Recreational, Bullish Analyst Says After Results

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) reported its financial results on Wednesday for the second quarter of fiscal 2022, revealing a 4% year-ove

Benzinga

Where Is The Cheapest Weed In America? A Close Look At Cannabis Pricing In PA And FL

Pablo Zuanic from Cantor Fitzgerald offered an industry update, covering cannabis pricing in Pennsylvania and Florida based on retailers’ menus. “Think of this report as 'food for thought' - we are not adjusting estimates or our investment views,” Zuanic said.

Benzinga

Here's What Investors Need To Know About Colombia's Cannabis Market, An Analysis Of Flora Growth's Earnings

Flora Growth Corp. (NASDAQ: FLGC) kicked off the week by

Benzinga

Reddit's Favorite Weed Stock SNDL Posts Staggering Revenue Growth, But Cantor Lowers Price Target

SNDL Inc.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Trulieve Cannabis: A Top Pick Operator In A Small Pond? Analyst Offers Model Update Post 2Q22

The Analyst Pablo Zuanic from Cantor Fitzgerald maintained a rating of Overweight for the stocks of Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) and lowered its price target to $54 from $57, on “slightly reduced estimates.”

Benzinga

Why Does This Undervalued Cannabis Stock Have An Encouraging Outlook?

The Analyst

Benzinga

What Makes A Bullish Sign For This Publicly Traded Cannabis Tech Company? Cantor Explains

Year-to-date, WM Technology (NASDAQ: MAPS) stock lost 44.90%, while over the last five years it plunged 64.73%.

Benzinga

Sen. Cory Booker Says He's Optimistic About Federal Marijuana Decriminalization After Signaling Possible Compromise

Weeks after the long-awaited marijuana decriminalization Senate bill was presented<

Benzinga

Cantor Analayst Pablo Zuanic Believes SAFE Banking Now "The Worst Case Scenario" in 2022

In perhaps a sign that incremental progress on federal cannabis reform is afoot, some Wall Street analysts are increasingly coming around on the idea that reform can happen this year. Cantor Fitzgerald analyst Pablo Zuanic, a noted skeptic on SAFE Banking, now believes the legislation has a real chance of…

Benzinga

Volatility Of Cannabis Stocks: Schumer's Bill Was A 'Hail Mary', But Industry Has Other Catalysts – Experts Explain

This was a very challenging year for pot stocks. Year-to-date, AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) dropped 54.01%, AdvisorShares Pure Cannabis ETF (ARCA:YOLO) declined 57.46%, compared to SPDR S&P 500 (ARCA:SPY) which lost 13.61%.

Benzinga

Are Nasdaq-Traded Colombian Cannabis Stocks Worth Buying? Yes And No, Says Analyst

Cantor Fitzgerald's analyst Pablo Zuanic initiated coverage on two cannabis companies on Monday: Flora Growth Corp. (NASDAQ: FLGC) and Clever Leaves Holdings Inc (NASDAQ: CLVR)

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cannabis In New Jersey: How Did The Market Change Since Recreational Weed Was Legalized?

On Thursday, Cantor Fitzgerald analyst Pablo Zuanic offered an update on New Jersey’s recreational cannabis market. Zuanic analyzed the competitive landscape and the changes in the recreational cannabis market in The Garden State. Although the report is not a second-quarter preview, the analyst offered an estimation of the evolution of…

Benzinga

Cantor Fitzgerald Downgrades Ratings On 2 Canadian Cannabis Stocks To Neutral, Here's Why

Cantor Fitzgerald analyst Pablo Zuanic downgraded his rating on two Canadian cannabis stocks, Auxly Cannabis Group Inc.

Benzinga

How To Get In Touch With The 5 Biggest Cannabis Operators In The US

While there’s no doubt that the federal legalization of marijuana would make the industry explode, current trends shouldn’t be underestimated.

Benzinga

This Analyst Is Bullish For Cannabis Stocks: Can Schumer's Bill Get 60 Votes In 'Holy Grail' Scenario?

Cantor Fitzgerald analyst Pablo Zuanic doubts that the Cannabis Administration And Opportunity Act (CAOA) will get the 60 votes it needs in the Senate in order to pass due to Republican opposition.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

This Analyst Expects Stabilization Across Canadian Cannabis Market, Revises Sales Estimates For Cannabis LPs

The Canadian cannabis industry has become a competitive field over the past few years, which doesn’t come as a surprise considering its exponential growth over the same period.

Benzinga

These Are The Top Cannabis Stock Picks According To 3 Of The Top Equity Analysts In The Marijuana Market

What are the best cannabis stocks to invest in right now?

Benzinga

OrganiGram Beat Fact Set Expectations: "The Stock Represents Good Value," Analyst Says

On Thursday, Organigram Holdings Inc. (OGI.TO) (NASDAQ: OGI), a cannabis company focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada,

Benzinga

Medical Marijuana Sales In US Plunge As Recreational Biz Bounces Back, Analyst Opines On Ways To Build Market Resilience

Federal legalization of cannabis seems to be moving slowly. However, states are lifting their bans on both medical and recreational marijuana one by one.

Benzinga

Cantor's Top Picks: Could Q2 Earnings Provide A Spark For These Cannabis Multi-State Operators?

Multi-State Operators (MSO) traded higher on Tuesday after Cantor Fitzgerald categorized four companies as "top picks." In a recent industry report, Pablo Zuanic analyzed the context of MSOs and offered insight on trends driving financial value. Although MSOs ETF fell 25% in June and 49% over the last three months (vs.

Benzinga

Sentiment For Tilray Stock Should Improve, This Analyst Tells Us Why

Germany is inching toward legalizing recreational cannabis as the government seeks to have the process completed by the end of 2022. The latest push is coming from the country’s Health Ministry which undertook exper

Benzinga

HEXO Deal Could Be A Big Win For Tilray, This Analyst Tells Us Why

On Wednesday HEXO Corp (NASDAQ: HEXO) reported a staggering loss of CA$152.7 million ($118 million) in the third quarter of 2022, representing a

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.